These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 752854)
41. Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study. Bolis G; Bortolozzi G; Carinelli G; D'Incalci M; Gramellini F; Morasca L; Mangioni C Cancer Chemother Pharmacol; 1980; 4(2):129-32. PubMed ID: 7389058 [TBL] [Abstract][Full Text] [Related]
42. Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung. Aisner J; Wiernik PH Cancer; 1980 Dec; 46(12):2543-9. PubMed ID: 6256048 [TBL] [Abstract][Full Text] [Related]
43. Immunochemotherapy in advanced neuroblastoma. Necheles TF; Rausen AR; Kung FH; Pochedly C Cancer; 1978 Apr; 41(4):1282-8. PubMed ID: 638992 [TBL] [Abstract][Full Text] [Related]
44. Treatment of early breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: initial results of a brief and effective adjuvant program. Salmon SE; Wendt A; Jones SE; Jackson R; Giordano G; Miller R; Heusinkveld R; Moon TE Recent Results Cancer Res; 1978; 68():98-104. PubMed ID: 223207 [No Abstract] [Full Text] [Related]
45. [Effectiveness of 3-drug therapy in patients with advanced ovarian cancer]. Kwaśniewska-Rokicińska C; Kaleta B; Kumor-Głodny T Ginekol Pol; 1989 Feb; 60(2):86-9. PubMed ID: 2680790 [TBL] [Abstract][Full Text] [Related]
46. Adjuvant therapy of stage II, III breast cancer. Buzdar AV; Gutterman JU; Blumenschein GR; Tashima CK; Hortobágyi GN; Yap HY; Hersh EM; Gehan EA Recent Results Cancer Res; 1978; 68():123-8. PubMed ID: 379930 [No Abstract] [Full Text] [Related]
48. Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapy. Hortobagyi GN; Blumenschein GR; Buzdar AU; Yap HY; Schell FC; Barnes BC; Burgess MA J Surg Oncol; 1981; 18(2):163-72. PubMed ID: 7300363 [TBL] [Abstract][Full Text] [Related]
49. Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study. Tranum BL; McDonald B; Thigpen T; Vaughn C; Wilson H; Maloney T; Costanzi J; Bickers J; el Mawli NG; Palmer R; Hoogstraten B; Heilburn L; Rasmusen S Cancer; 1982 Mar; 49(5):835-9. PubMed ID: 7037152 [No Abstract] [Full Text] [Related]
50. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878. Wadler S; Yeap B; Vogl S; Carbone P Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766 [TBL] [Abstract][Full Text] [Related]
51. Therapy of endodermal sinus tumor of the ovary. Gallion H; van Nagell JR; Powell DF; Donaldson ES; Hanson M Am J Obstet Gynecol; 1979 Oct; 135(4):447-51. PubMed ID: 484642 [TBL] [Abstract][Full Text] [Related]
52. Adriamycin in combination for the treatment of breast cancer: a Southwest Oncology Group study. Tranum B; Hoogstraten B; Kennedy A; Vaughn CB; Samal B; Thigpen T; Rivkin S; Smith F; Palmer RL; Costanzi J; Tucker WG; Wilson H; Maloney TR Cancer; 1978 Jun; 41(6):2078-83. PubMed ID: 657081 [TBL] [Abstract][Full Text] [Related]
53. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study. Hoogstraten B; George SL; Samal B; Rivkin SE; Costanzi JJ; Bonnet JD; Thigpen T; Braine H Cancer; 1976 Jul; 38(1):13-20. PubMed ID: 947510 [TBL] [Abstract][Full Text] [Related]
54. Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group Study. Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Talley R; Butler JJ; Byrne GE; Hartsock R; Dixon D; Salmon SE Cancer; 1983 Mar; 51(6):1083-90. PubMed ID: 6185212 [TBL] [Abstract][Full Text] [Related]
55. Single-agent adriamycin followed by combination hexamethylmelamine-cyclophosphamide for advanced ovarian carcinoma. Wharton JT; Herson J; Edwards CL; Griffith AB Gynecol Oncol; 1982 Oct; 14(2):262-70. PubMed ID: 6813202 [No Abstract] [Full Text] [Related]
56. [Intermittent administration of the combination chemotherapy with cis-platin, adriamycin and cyclophosphamide (cyclic-PAC chemotherapy) for the ovarian cancers]. Inoue M; Nakanishi K; Nakazawa A; Ogawa H; Shimizu H; Saitoh J; Tanaka Y; Ueda G; Tanizawa O Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):347-52. PubMed ID: 2358719 [TBL] [Abstract][Full Text] [Related]
57. [Controlled prospective study of chemotherapy in advanced ovarian cancer--cyclophosphamide monochemotherapy versus polychemotherapy with adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate]. Chylak V; Kolarić K; Krusić J Lijec Vjesn; 1987 Jun; 109(6):230-4. PubMed ID: 3309515 [No Abstract] [Full Text] [Related]
58. Endodermal sinus tumor of the ovary: the M. D. Anderson experience. Gershenson DM; Del Junco G; Herson J; Rutledge FN Obstet Gynecol; 1983 Feb; 61(2):194-202. PubMed ID: 6185892 [TBL] [Abstract][Full Text] [Related]
59. Combination therapy for advanced breast cancer: cyclophosphamide, doxorubicin, UFT, and tamoxifen. Fukuda M; Yamaguchi S; Ohta T; Nakayama Y; Ogata H; Shimizu K; Nishikawa T; Adachi Y; Fukuma E Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):77-81. PubMed ID: 10442369 [TBL] [Abstract][Full Text] [Related]